Multiple Dose Study of D1971a in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Healthy
Interventions
DRUG

DS-1971a

DS 1971a is supplied as a powder or crystals and will be given as an oral suspension

DRUG

Placebo

Placebo matching DS-1971a suspension

Trial Locations (1)

Unknown

Mammersmith Medicines Research Ltd., London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY